A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults
Keywords: RTS,S; Malaria; Vaccine; Falciparum; Plasmodium; Antigens; Adjuvant; Clinical trials; AS02A; Circumsporozoite protein;